$205.99
-1.40%
N/A-$2.93
Healthcare
Drug Manufacturers - General
NASDAQ
Active Trading
Biogen Inc. is a leading biotechnology firm dedicated to the discovery, development, production, and distribution of treatments for complex neurological and neurodegenerative ...
C-Suite Executives
(0)The C-suite executives form a cohesive leadership team driving the company's financial strategy and innovation.
Key Team Members
No executives available for this level
Founder / CEO
1
C-Level
13
VP
0
Board
0
Director / Board
1
Other
0
Key Executives
| Name | Title | Compensation | Gender | Year Born | Status |
|---|---|---|---|---|---|
| Christopher A. Viehbacher | President, Chief Executive Officer & Director | USD 5,277,129 | 1961 | Active | |
| Susan H. Alexander | Executive Vice President & Chief Legal Officer | USD 2,249,670 | 1957 | Active | |
| Nicole Murphy | Executive Vice President and Head of Pharmaceutical Operations & Technology | USD 2,009,424 | 1973 | Active | |
| Priya Singhal | Executive Vice President & Head of Development | USD 2,005,306 | — | 1968 | Active |
| Robin C. Kramer | Executive Vice President & Chief Financial Officer | USD 1,632,803 | 1966 | Active | |
| Ginger Gregory | Executive Vice President & Chief Human Resources Officer | USD 1,590,428 | — | 1968 | Active |
| Rachid Izzar | Executive Vice President and Head of Global Product Strategy & Commercialization | USD 1,265,286 | 1975 | Active | |
| Guy Hadari | Chief Information Officer | — | — | Active | |
| Wolfram Schmidt | President & Head of Europe | — | — | — | Active |
| Natacha Gassenbach | Chief Communication Officer & Head of Corporate Affairs | — | — | Active | |
| Alisha A. Alaimo | President & Head of North America | — | — | Active | |
| Fraser Hall | President & Head of Intercontinental Region | — | — | Active | |
| Sean Godbout | VP, Chief Accounting Officer & Global Corporate Controller | — | 1974 | Active | |
| Tim Power | Head of Investor Relations | — | — | Active | |
| Adam Keeney | Executive Vice President & Head of Corporate Development | — | 1977 | Active |
Executive Compensation
(deduped by latest filing date per person-year)| Filing Date | Year | Name | Position | Level | Salary | Bonus | Stock Award | Option Award | Incentive | Other | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-28 | 2025 | Christopher A. Viehbacher | President President and Chief Chief Executive Officer | Founder / CEO | $1.73M | $0 | $18.37M | $0 | $3.19M | $358.37K | $23.65M |
| 2026-04-28 | 2025 | Susan H. Alexander Executive | Vice Vice President President, Chief Chief Legal Officer | C-Level | $1.03M | $0 | $5.85M | $0 | $1.06M | $197.06K | $8.13M |
| 2026-04-28 | 2025 | Nicole C. Murphy Head of Pharmaceutical Operations and Technology | — | Other | $909.11K | $0 | $5.57M | $0 | $977.83K | $122.49K | $7.58M |
| 2026-04-28 | 2025 | Priya A. Singhal Head of Development | — | Other | $929.71K | $898 | $5.57M | $0 | $950.83K | $123.86K | $7.57M |
| 2026-04-28 | 2025 | Robin C. Kramer Executive | Vice Vice President President and Chief Chief Financial Officer | C-Level | $759.62K | $0 | $4.17M | $0 | $788.25K | $84.93K | $5.81M |
| 2026-04-28 | 2025 | Michael R. McDonnell | Former Former Executive Vice Vice President President and Chief Chief Financial Officer | C-Level | $226.90K | $0 | $0 | $0 | $0 | $43.95K | $270.85K |
| 2026-04-28 | 2024 | Christopher A. Viehbacher | President President and Chief Chief Executive Officer | Founder / CEO | $1.60M | $0 | $18.01M | $0 | $4.31M | $247.27K | $24.17M |
| 2026-04-28 | 2024 | Michael R. McDonnell | Former Former Executive Vice Vice President President and Chief Chief Financial Officer | C-Level | $992.53K | $0 | $4.43M | $0 | $1.21M | $188.35K | $6.83M |
| 2025-04-28 | 2024 | Michael R. McDonnell Executive | Vice Vice President President, Chief Chief Financial Officer | C-Level | $992.53K | $0 | $4.43M | $0 | $1.21M | $188.35K | $6.83M |
| 2026-04-28 | 2024 | Susan H. Alexander Executive | Vice Vice President President, Chief Chief Legal Officer | C-Level | $954.19K | $0 | $3.88M | $0 | $1.52M | $155.88K | $6.51M |
| 2026-04-28 | 2024 | Priya A. Singhal Head of Development | — | Other | $816.35K | $0 | $4.43M | $0 | $1.02M | $116.52K | $6.39M |
| 2026-04-28 | 2024 | Nicole C. Murphy Head of Pharmaceutical Operations and Technology | — | Other | $764.57K | $0 | $3.88M | $0 | $999.03K | $97.54K | $5.74M |
| 2026-04-28 | 2023 | Michael R. McDonnell | Former Former Executive Vice Vice President President and Chief Chief Financial Officer | C-Level | $945.27K | $0 | $4.96M | $0 | $1.13M | $132.52K | $7.17M |
| 2025-04-28 | 2023 | Michael R. McDonnell Executive | Vice Vice President President, Chief Chief Financial Officer | C-Level | $945.27K | $0 | $4.96M | $0 | $1.13M | $132.52K | $7.17M |
| 2026-04-28 | 2023 | Susan H. Alexander Executive | Vice Vice President President, Chief Chief Legal Officer | C-Level | $924.42K | $0 | $4.60M | $0 | $846.61K | $331.88K | $6.70M |
| 2026-04-28 | 2023 | Nicole C. Murphy Head of Pharmaceutical Operations and Technology | — | Other | $670.64K | $0 | $4.27M | $0 | $676.60K | $98.62K | $5.71M |
| 2024-04-26 | 2023 | Rachid Izzar Head of Global Product Strategy & Commercialization | — | Other | $591.18K | $0 | $4.18M | $0 | $574.09K | $100.02K | $5.45M |
| 2026-04-28 | 2023 | Christopher A. Viehbacher | President President and Chief Chief Executive Officer | Founder / CEO | $1.60M | $0 | $0 | $0 | $2.38M | $93.91K | $4.07M |
| 2025-04-28 | 2022 | Christopher A. Viehbacher | President President and CEO CEO | Founder / CEO | $153.85K | $0 | $18.80M | $11.20M | $315.62K | $18.48K | $30.49M |
| 2023-04-28 | 2022 | Michel Vounatsos | Former Former Chief Chief Executive Officer | Founder / CEO | $1.63M | $0 | $15.39M | $0 | $0 | $9.61M | $26.63M |
| 2025-04-28 | 2022 | Michael R. McDonnell Executive | Vice Vice President President, Chief Chief Financial Officer | C-Level | $901.31K | $0 | $5.08M | $0 | $1.11M | $117.59K | $7.21M |
| 2025-04-28 | 2022 | Susan H. Alexander Executive | Vice Vice President President, Chief Chief Legal Officer | C-Level | $879.41K | $0 | $4.16M | $0 | $1.18M | $578.03K | $6.79M |
| 2023-04-28 | 2022 | Chirfi Guindo | Former Former Executive Vice Vice President President, Global Product Strategy and Commercialization | C-Level | $372.82K | $0 | $4.92M | $0 | $0 | $92.95K | $5.38M |
| 2023-04-28 | 2022 | Ginger Gregory Executive | Vice Vice President President, Chief Chief Human Resources Officer | C-Level | $659.36K | $0 | $3.49M | $0 | $827.53K | $103.70K | $5.08M |
| 2025-04-28 | 2022 | Nicole C. Murphy Head of Pharmaceutical Operations and Technology | — | Other | $592.22K | $0 | $3.47M | $0 | $729.57K | $136.66K | $4.93M |
| 2023-04-28 | 2022 | Nicole C. Murphy Executive | Vice Vice President President, Head of Pharmaceutical Operations and Technology | C-Level | $592.22K | $0 | $3.47M | $0 | $729.57K | $136.66K | $4.93M |
| 2023-04-28 | 2021 | Michel Vounatsos | Former Former Chief Chief Executive Officer | Founder / CEO | $1.53M | $0 | $14.08M | $0 | $1.15M | $919.05K | $17.69M |
| 2024-04-26 | 2021 | Michael R. McDonnell Executive | Vice Vice President President and Chief Chief Financial Officer | C-Level | $868.80K | $0 | $4.06M | $0 | $836.40K | $150.88K | $5.92M |
| 2023-04-28 | 2021 | Chirfi Guindo | Former Former Executive Vice Vice President President, Global Product Strategy and Commercialization | C-Level | $618.51K | $0 | $4.48M | $0 | $586.14K | $69.05K | $5.75M |
| 2022-04-29 | 2021 | Chirfi Guindo Executive | Vice Vice President President, Global Product Strategy And Commercialization | C-Level | $618.51K | $0 | $4.48M | $0 | $0 | $0 | $5.75M |
| 2022-04-29 | 2021 | Alfred W. Sandrock, Jr. | Former Former Executive Vice Vice President President, Research & Development | C-Level | $921.62K | $0 | $4.48M | $0 | $0 | $340.69K | $5.74M |
| 2024-04-26 | 2021 | Susan H. Alexander Executive | Vice Vice President President, Chief Chief Legal Officer | C-Level | $832.17K | $0 | $3.41M | $0 | $813.66K | $584.56K | $5.64M |
| 2023-04-28 | 2020 | Michel Vounatsos | Former Former Chief Chief Executive Officer | Founder / CEO | $1.49M | $0 | $13.89M | $0 | $2.56M | $719.30K | $18.66M |
| 2021-04-23 | 2020 | Jeffrey D. Capello | Former Former Executive Vice Vice President President and Chief Chief Financial Officer | C-Level | $671.13K | $0 | $3.90M | $0 | $0 | $4.65M | $9.22M |
| 2023-04-28 | 2020 | Michael R. McDonnell Executive | Vice Vice President President and Chief Chief Financial Officer | C-Level | $294.23K | $1.00M | $5.01M | $0 | $263.32K | $5.70K | $6.58M |
| 2022-04-29 | 2020 | Alfred W. Sandrock, Jr. | Former Former Executive Vice Vice President President, Research & Development | C-Level | $890.31K | $0 | $4.33M | $0 | $0 | $285.46K | $6.23M |
| 2021-04-23 | 2020 | Alfred W. Sandrock, Jr. Executive | Vice Vice President President, Research & Development | C-Level | $890.31K | $0 | $4.33M | $0 | $719.54K | $285.46K | $6.23M |
| 2023-04-28 | 2020 | Susan H. Alexander Executive | Vice Vice President President, Chief Chief Legal Officer and Secretary | C-Level | $809.70K | $0 | $3.58M | $0 | $606.39K | $470.68K | $5.47M |
| 2023-04-28 | 2020 | Chirfi Guindo | Former Former Executive Vice Vice President President, Global Product Strategy and Commercialization | C-Level | $562.82K | $0 | $3.96M | $0 | $527.97K | $80.72K | $5.13M |
| 2022-04-29 | 2020 | Chirfi Guindo Executive | Vice Vice President President, Global Product Strategy And Commercialization | C-Level | $562.82K | $0 | $3.96M | $0 | $0 | $0 | $5.13M |
| 2022-04-29 | 2019 | Michel Vounatsos | Chief Chief Executive Officer | Founder / CEO | $1.39M | $0 | $12.35M | $0 | $3.88M | $449.70K | $18.16M |
| 2021-04-23 | 2019 | Jeffrey D. Capello | Former Former Executive Vice Vice President President and Chief Chief Financial Officer | C-Level | $783.17K | $0 | $4.05M | $0 | $883.58K | $95.45K | $5.81M |
| 2020-04-20 | 2019 | Jeffrey D. Capello Executive | Vice Vice President President and Chief Chief Financial Officer | C-Level | $783.17K | $0 | $4.05M | $0 | $883.58K | $95.45K | $5.81M |
| 2022-04-29 | 2019 | Susan H. Alexander Executive | Vice Vice President President, Chief Chief Legal Officer And Secretary | C-Level | $772.37K | $0 | $3.30M | $0 | $1.03M | $346.57K | $5.46M |
| 2022-04-29 | 2019 | Alfred W. Sandrock, Jr. | Former Former Executive Vice Vice President President, Research & Development | C-Level | $798.72K | $0 | $3.36M | $0 | $719.54K | $181.62K | $5.31M |
| 2021-04-23 | 2019 | Alfred W. Sandrock, Jr. Executive | Vice Vice President President, Research & Development | C-Level | $798.72K | $0 | $3.36M | $0 | $893.04K | $260.12K | $5.31M |
| 2020-04-20 | 2019 | Michael D. Ehlers | Former Former Executive Vice Vice President President Research & Development | C-Level | $708.34K | $0 | $4.40M | $0 | $0 | $178.47K | $5.29M |
| 2022-04-29 | 2019 | Chirfi Guindo Executive | Vice Vice President President, Global Product Strategy And Commercialization | C-Level | $526.54K | $0 | $3.38M | $0 | $0 | $0 | $4.69M |
| 2021-04-23 | 2018 | Michel Vounatsos | Chief Chief Executive Officer | Founder / CEO | $1.28M | $0 | $11.06M | $0 | $3.34M | $488.95K | $16.17M |
| 2020-04-20 | 2018 | Michael D. Ehlers | Former Former Executive Vice Vice President President Research & Development | C-Level | $829.51K | $0 | $5.11M | $0 | $917.84K | $191.77K | $7.05M |
| 2019-04-30 | 2018 | Michael D. Ehlers Executive | Vice Vice President President, Research & Development | C-Level | $829.51K | $0 | $5.11M | $0 | $917.84K | $191.77K | $7.05M |
| 2021-04-23 | 2018 | Susan H. Alexander Executive | Vice Vice President President, Chief Chief Legal Officer And Secretary | C-Level | $746.25K | $0 | $4.36M | $0 | $858.74K | $389.20K | $6.35M |
| 2021-04-23 | 2018 | Jeffrey D. Capello | Former Former Executive Vice Vice President President and Chief Chief Financial Officer | C-Level | $750.00K | $0 | $2.89M | $0 | $790.91K | $46.58K | $4.48M |
| 2020-04-20 | 2018 | Jeffrey D. Capello Executive | Vice Vice President President and Chief Chief Financial Officer | C-Level | $750.00K | $0 | $2.89M | $0 | $790.91K | $46.58K | $4.48M |
| 2020-04-20 | 2017 | Michel Vounatsos | Chief Chief Executive Officer | Founder / CEO | $1.09M | $0 | $9.87M | $0 | $2.50M | $205.45K | $13.66M |
| 2020-04-20 | 2017 | Michael D. Ehlers | Former Former Executive Vice Vice President President Research & Development | C-Level | $792.14K | $0 | $3.16M | $0 | $1.01M | $103.47K | $5.06M |
| 2020-04-20 | 2017 | Susan H. Alexander Executive | Vice Vice President President, Chief Chief Legal Officer and Secretary | C-Level | $720.63K | $0 | $3.16M | $0 | $856.30K | $326.97K | $5.06M |
| 2020-04-20 | 2017 | Jeffrey D. Capello Executive | Vice Vice President President and Chief Chief Financial Officer | C-Level | $28.85K | $520.00K | $0 | $0 | $0 | $132 | $548.98K |
| 2019-04-30 | 2016 | Michel Vounatsos | Chief Chief Executive Officer | Founder / CEO | $519.23K | $1.50M | $3.15M | $0 | $447.80K | $183.17K | $5.80M |
| 2019-04-30 | 2016 | Michael D. Ehlers Executive | Vice Vice President President, Research & Development | C-Level | $491.83K | $1.17M | $3.41M | $0 | $425.06K | $14.82K | $5.51M |
Total Compensation Trend
Sum of disclosed compensation by year (USD million)
Key Roles Compensation Lines
Top founder/C-level executives over time (USD million)